Loading…
image

Report Scope & Overview:

Automated Breast Ultrasound Systems (ABUS) Market accounted for US$ 1.74 billion in 2022 and is estimated to be US$ 8.52 billion by 2032 and is anticipated to register a CAGR of 17.4% from 2032 to 2032

Executive Summary:
The global Automated Breast Ultrasound Systems (ABUS) market is expected to experience significant growth due to various factors such as increasing demand for the product, the presence of key market players, and advancements in technology. This report provides an in-depth analysis of the market size, growth trends, pricing structure, production, value chain analysis, and regional assessment. The report also offers insights into company profiling and emerging product lines.

Overview: Automated Breast Ultrasound Systems (ABUS) are medical imaging devices designed for breast cancer screening. Unlike traditional hand-held ultrasound, ABUS is an automated system that captures 3D ultrasound images of the entire breast. ABUS is particularly useful in screening women with dense breast tissue, where mammography may be less effective.

Market Size and Growth: The market for ABUS has seen growth in recent years, driven by factors such as increasing awareness of breast cancer, the need for more accurate and reliable diagnostic tools, and advancements in medical imaging technologies. The adoption of ABUS has been influenced by its ability to provide supplemental screening for women with dense breasts, where mammography alone may not be sufficient.

Key Factors Driving the Market:

  1. Dense Breast Tissue Awareness: The recognition that dense breast tissue is a risk factor for breast cancer and that it can reduce the effectiveness of mammography has led to an increased demand for supplementary screening methods like ABUS.

  2. Advancements in Technology: Ongoing advancements in ultrasound technology, including improvements in image resolution, automation, and 3D imaging capabilities, contribute to the adoption of ABUS.

  3. Rising Incidence of Breast Cancer: The global increase in breast cancer incidence has driven the demand for more accurate and early detection methods, supporting the growth of the ABUS market.

Challenges:

  1. Costs: The initial costs associated with acquiring and implementing ABUS technology can be a challenge for healthcare facilities, limiting widespread adoption.

  2. Regulatory Compliance: Regulatory approval processes and compliance with medical device regulations can impact the introduction and market penetration of ABUS products.

  3. Awareness and Education: There may be a need for increased awareness and education among healthcare professionals and the general public about the benefits and role of ABUS in breast cancer screening.

Future Outlook: The ABUS market is expected to continue evolving with ongoing technological advancements, improvements in screening protocols, and increased adoption. As the awareness of the limitations of mammography in certain populations grows, ABUS is likely to play an increasingly important role in breast cancer detection and diagnosis.

Market Segmentations:

Global Automated Breast Ultrasound Systems (ABUS) Market: By Company
• GE Healthcare
• Hitachi
• Koninklijke Philips N.V.
• Siemens
• SonoCine
• QView Medical
• Seno Medical Instruments
• Volpara Solutions
• Delphinus Medical Technologies
• CapeRay
• SuperSonic Imagine
• Nova Medical Imaging TechnologyLtd.
• Shantou Institute of Ultrasonic Instruments (SIUI)
• Theraclion
• Real Imaging
• MetriTrack
• Toshiba Company

Global Automated Breast Ultrasound Systems (ABUS) Market: By Type
• Automated Breast Ultrasound Systems(ABUS)
• Automated Breast Volume Scanner (ABVS)

Global Automated Breast Ultrasound Systems (ABUS) Market: By Application
• Hosptials
• Diagnostic Imaging Centers
• Others

Global Automated Breast Ultrasound Systems (ABUS) Market: Regional Analysis
The regional analysis of the global Automated Breast Ultrasound Systems (ABUS) market provides insights into the market's performance across different regions of the world. The analysis is based on recent and future trends and includes market forecast for the prediction period. The countries covered in the regional analysis of the Automated Breast Ultrasound Systems (ABUS) market report are as follows:

North America: The North America region includes the U.S., Canada, and Mexico. The U.S. is the largest market for Automated Breast Ultrasound Systems (ABUS) in this region, followed by Canada and Mexico. The market growth in this region is primarily driven by the presence of key market players and the increasing demand for the product.

Europe: The Europe region includes Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe. Germany is the largest market for Automated Breast Ultrasound Systems (ABUS) in this region, followed by the U.K. and France. The market growth in this region is driven by the increasing demand for the product in the automotive and aerospace sectors.

Asia-Pacific: The Asia-Pacific region includes Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, and Rest of Asia-Pacific. China is the largest market for Automated Breast Ultrasound Systems (ABUS) in this region, followed by Japan and India. The market growth in this region is driven by the increasing adoption of the product in various end-use industries, such as automotive, aerospace, and construction.

Middle East and Africa: The Middle East and Africa region includes Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa. The market growth in this region is driven by the increasing demand for the product in the aerospace and defense sectors.

South America: The South America region includes Argentina, Brazil, and Rest of South America. Brazil is the largest market for Automated Breast Ultrasound Systems (ABUS) in this region, followed by Argentina. The market growth in this region is primarily driven by the increasing demand for the product in the automotive sector.
Report Attribute/MetricDetails
Market Size 2022US$ 1.74 Billion 
Market Size 2032US$ 8.52 Billion 
Compound Annual Growth Rate (CAGR)17.4%(2023-2032)
Base Year2023
Forecast Period2024-2033
Historical Data2018-2023
Forecast UnitsValue (US$ Billion )
Report CoverageRevenue Forecast, Competitive Landscape,
Growth Factors, and Trends 
By Type• Automated Breast Ultrasound Systems(ABUS)
• Automated Breast Volume Scanner (ABVS)


By Application• Hosptials
• Diagnostic Imaging Centers
Key Companies Profiled• GE Healthcare
• Hitachi
• Koninklijke Philips N.V.
• Siemens
• SonoCine
• QView Medical
• Seno Medical Instruments
• Volpara Solutions
• Delphinus Medical Technologies
• CapeRay
• SuperSonic Imagine
• Nova Medical Imaging TechnologyLtd.
• Shantou Institute of Ultrasonic Instruments (SIUI)
• Theraclion
• Real Imaging
• MetriTrack
• Toshiba Company


Regions and Key Countries CoveredU.S., Canada, and Mexico in North America, Germany, France, U.K.,
Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium,
and Rest of Europe in Europe, Singapore, Malaysia, Australia,
Thailand, Indonesia, Philippines, China, Japan, India,
South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E, South Africa, Egypt, Israel,
Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA),
and Argentina, Brazil, and Rest of South America as part of South America
Customization ScopeAvailable on Request

Reasons to Purchase Automated Breast Ultrasound Systems (ABUS) Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.

Objectives of Automated Breast Ultrasound Systems (ABUS) Market Study:
The objectives of Automated Breast Ultrasound Systems (ABUS) market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Automated Breast Ultrasound Systems (ABUS) market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.

Frequently Asked Questions

  Automated Breast Ultrasound Systems (ABUS) Market accounted for US$ 1.74 billion in 2022 and is estimated to be US$ 8.52 billion by 2032 and is anticipated to register a CAGR of 17.4% from 2032 to 2032

  Factors such as increasing breast cancer prevalence, advancements in ultrasound technology, and the need for supplementary breast cancer screening are driving market growth.

  Key players include GE Healthcare, Siemens Healthineers, Hitachi, SonoCine Inc., and others.

  Challenges include the high cost of ABUS systems, limited awareness among healthcare professionals, and varying reimbursement policies.

  Continuous technological advancements, such as the development of 3D ABUS and artificial intelligence integration, are enhancing the capabilities and accuracy of ABUS systems.

TABLE OF CONTENT

1 Automated Breast Ultrasound Systems (ABUS) Market Overview
1.1 Product Overview and Scope of Automated Breast Ultrasound Systems (ABUS)
1.2 Automated Breast Ultrasound Systems (ABUS) Segment by Type
1.2.1 Global Automated Breast Ultrasound Systems (ABUS) Market Value Comparison by Type (2023-2029)
1.2.2 Automated Breast Ultrasound Systems(ABUS)
1.2.3 Automated Breast Volume Scanner (ABVS)
1.3 Automated Breast Ultrasound Systems (ABUS) Segment by Application
1.3.1 Global Automated Breast Ultrasound Systems (ABUS) Market Value by Application: (2023-2029)
1.3.2 Hosptials
1.3.3 Diagnostic Imaging Centers
1.3.4 Others
1.4 Global Automated Breast Ultrasound Systems (ABUS) Market Size Estimates and Forecasts
1.4.1 Global Automated Breast Ultrasound Systems (ABUS) Revenue 2018-2029
1.4.2 Global Automated Breast Ultrasound Systems (ABUS) Sales 2018-2029
1.4.3 Global Automated Breast Ultrasound Systems (ABUS) Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Automated Breast Ultrasound Systems (ABUS) Market Competition by Manufacturers
2.1 Global Automated Breast Ultrasound Systems (ABUS) Sales Market Share by Manufacturers (2017-2023)
2.2 Global Automated Breast Ultrasound Systems (ABUS) Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Automated Breast Ultrasound Systems (ABUS) Average Price by Manufacturers (2017-2023)
2.4 Global Automated Breast Ultrasound Systems (ABUS) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Automated Breast Ultrasound Systems (ABUS), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automated Breast Ultrasound Systems (ABUS), Product Type & Application
2.7 Automated Breast Ultrasound Systems (ABUS) Market Competitive Situation and Trends
2.7.1 Automated Breast Ultrasound Systems (ABUS) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automated Breast Ultrasound Systems (ABUS) Players Market Share by Revenue
2.7.3 Global Automated Breast Ultrasound Systems (ABUS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automated Breast Ultrasound Systems (ABUS) Retrospective Market Scenario by Region
3.1 Global Automated Breast Ultrasound Systems (ABUS) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Automated Breast Ultrasound Systems (ABUS) Global Automated Breast Ultrasound Systems (ABUS) Sales by Region: 2018-2029
3.2.1 Global Automated Breast Ultrasound Systems (ABUS) Sales by Region: 2018-2023
3.2.2 Global Automated Breast Ultrasound Systems (ABUS) Sales by Region: 2024-2029
3.3 Global Automated Breast Ultrasound Systems (ABUS) Global Automated Breast Ultrasound Systems (ABUS) Revenue by Region: 2018-2029
3.3.1 Global Automated Breast Ultrasound Systems (ABUS) Revenue by Region: 2018-2023
3.3.2 Global Automated Breast Ultrasound Systems (ABUS) Revenue by Region: 2024-2029
3.4 North America Automated Breast Ultrasound Systems (ABUS) Market Facts & Figures by Country
3.4.1 North America Automated Breast Ultrasound Systems (ABUS) Market Size by Country: 2018 VS 2023 VS 2032
3.4.2 North America Automated Breast Ultrasound Systems (ABUS) Sales by Country (2017-2032)
3.4.3 North America Automated Breast Ultrasound Systems (ABUS) Revenue by Country (2017-2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Automated Breast Ultrasound Systems (ABUS) Market Facts & Figures by Country
3.5.1 Europe Automated Breast Ultrasound Systems (ABUS) Market Size by Country: 2018 VS 2023 VS 2032
3.5.2 Europe Automated Breast Ultrasound Systems (ABUS) Sales by Country (2017-2032)
3.5.3 Europe Automated Breast Ultrasound Systems (ABUS) Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automated Breast Ultrasound Systems (ABUS) Market Facts & Figures by Country
3.6.1 Asia Pacific Automated Breast Ultrasound Systems (ABUS) Market Size by Country: 2018 VS 2023 VS 2032
3.6.2 Asia Pacific Automated Breast Ultrasound Systems (ABUS) Sales by Country (2017-2032)
3.6.3 Asia Pacific Automated Breast Ultrasound Systems (ABUS) Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Automated Breast Ultrasound Systems (ABUS) Market Facts & Figures by Country
3.7.1 Latin America Automated Breast Ultrasound Systems (ABUS) Market Size by Country: 2018 VS 2023 VS 2032
3.7.2 Latin America Automated Breast Ultrasound Systems (ABUS) Sales by Country (2017-2032)
3.7.3 Latin America Automated Breast Ultrasound Systems (ABUS) Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automated Breast Ultrasound Systems (ABUS) Market Facts & Figures by Country
3.8.1 Middle East and Africa Automated Breast Ultrasound Systems (ABUS) Market Size by Country: 2018 VS 2023 VS 2032
3.8.2 Middle East and Africa Automated Breast Ultrasound Systems (ABUS) Sales by Country (2017-2032)
3.8.3 Middle East and Africa Automated Breast Ultrasound Systems (ABUS) Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Automated Breast Ultrasound Systems (ABUS) Sales by Type (2017-2032)
4.1.1 Global Automated Breast Ultrasound Systems (ABUS) Sales by Type (2017-2023)
4.1.2 Global Automated Breast Ultrasound Systems (ABUS) Sales by Type (2023-2032)
4.1.3 Global Automated Breast Ultrasound Systems (ABUS) Sales Market Share by Type (2017-2032)
4.2 Global Automated Breast Ultrasound Systems (ABUS) Revenue by Type (2017-2032)
4.2.1 Global Automated Breast Ultrasound Systems (ABUS) Revenue by Type (2017-2023)
4.2.2 Global Automated Breast Ultrasound Systems (ABUS) Revenue by Type (2023-2032)
4.2.3 Global Automated Breast Ultrasound Systems (ABUS) Revenue Market Share by Type (2017-2032)
4.3 Global Automated Breast Ultrasound Systems (ABUS) Price by Type (2017-2032)
5 Segment by Application
5.1 Global Automated Breast Ultrasound Systems (ABUS) Sales by Application (2017-2032)
5.1.1 Global Automated Breast Ultrasound Systems (ABUS) Sales by Application (2017-2023)
5.1.2 Global Automated Breast Ultrasound Systems (ABUS) Sales by Application (2023-2032)
5.1.3 Global Automated Breast Ultrasound Systems (ABUS) Sales Market Share by Application (2017-2032)
5.2 Global Automated Breast Ultrasound Systems (ABUS) Revenue by Application (2017-2032)
5.2.1 Global Automated Breast Ultrasound Systems (ABUS) Revenue by Application (2017-2023)
5.2.2 Global Automated Breast Ultrasound Systems (ABUS) Revenue by Application (2023-2032)
5.2.3 Global Automated Breast Ultrasound Systems (ABUS) Revenue Market Share by Application (2017-2032)
5.3 Global Automated Breast Ultrasound Systems (ABUS) Price by Application (2017-2032)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.1.4 GE Healthcare Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Hitachi
6.2.1 Hitachi Corporation Information
6.2.2 Hitachi Description and Business Overview
6.2.3 Hitachi Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Hitachi Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.2.5 Hitachi Recent Developments/Updates
6.3 Koninklijke Philips N.V.
6.3.1 Koninklijke Philips N.V. Corporation Information
6.3.2 Koninklijke Philips N.V. Description and Business Overview
6.3.3 Koninklijke Philips N.V. Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Koninklijke Philips N.V. Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.3.5 Koninklijke Philips N.V. Recent Developments/Updates
6.4 Siemens
6.4.1 Siemens Corporation Information
6.4.2 Siemens Description and Business Overview
6.4.3 Siemens Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Siemens Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.4.5 Siemens Recent Developments/Updates
6.5 SonoCine
6.5.1 SonoCine Corporation Information
6.5.2 SonoCine Description and Business Overview
6.5.3 SonoCine Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.5.4 SonoCine Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.5.5 SonoCine Recent Developments/Updates
6.6 QView Medical
6.6.1 QView Medical Corporation Information
6.6.2 QView Medical Description and Business Overview
6.6.3 QView Medical Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.6.4 QView Medical Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.6.5 QView Medical Recent Developments/Updates
6.7 Seno Medical Instruments
6.6.1 Seno Medical Instruments Corporation Information
6.6.2 Seno Medical Instruments Description and Business Overview
6.6.3 Seno Medical Instruments Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Seno Medical Instruments Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.7.5 Seno Medical Instruments Recent Developments/Updates
6.8 Volpara Solutions
6.8.1 Volpara Solutions Corporation Information
6.8.2 Volpara Solutions Description and Business Overview
6.8.3 Volpara Solutions Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Volpara Solutions Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.8.5 Volpara Solutions Recent Developments/Updates
6.9 Delphinus Medical Technologies
6.9.1 Delphinus Medical Technologies Corporation Information
6.9.2 Delphinus Medical Technologies Description and Business Overview
6.9.3 Delphinus Medical Technologies Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Delphinus Medical Technologies Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.9.5 Delphinus Medical Technologies Recent Developments/Updates
6.10 CapeRay
6.10.1 CapeRay Corporation Information
6.10.2 CapeRay Description and Business Overview
6.10.3 CapeRay Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.10.4 CapeRay Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.10.5 CapeRay Recent Developments/Updates
6.11 SuperSonic Imagine
6.11.1 SuperSonic Imagine Corporation Information
6.11.2 SuperSonic Imagine Automated Breast Ultrasound Systems (ABUS) Description and Business Overview
6.11.3 SuperSonic Imagine Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.11.4 SuperSonic Imagine Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.11.5 SuperSonic Imagine Recent Developments/Updates
6.12 Nova Medical Imaging TechnologyLtd.
6.12.1 Nova Medical Imaging TechnologyLtd. Corporation Information
6.12.2 Nova Medical Imaging TechnologyLtd. Automated Breast Ultrasound Systems (ABUS) Description and Business Overview
6.12.3 Nova Medical Imaging TechnologyLtd. Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.12.4 Nova Medical Imaging TechnologyLtd. Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.12.5 Nova Medical Imaging TechnologyLtd. Recent Developments/Updates
6.13 Shantou Institute of Ultrasonic Instruments (SIUI)
6.13.1 Shantou Institute of Ultrasonic Instruments (SIUI) Corporation Information
6.13.2 Shantou Institute of Ultrasonic Instruments (SIUI) Automated Breast Ultrasound Systems (ABUS) Description and Business Overview
6.13.3 Shantou Institute of Ultrasonic Instruments (SIUI) Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.13.4 Shantou Institute of Ultrasonic Instruments (SIUI) Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.13.5 Shantou Institute of Ultrasonic Instruments (SIUI) Recent Developments/Updates
6.14 Theraclion
6.14.1 Theraclion Corporation Information
6.14.2 Theraclion Automated Breast Ultrasound Systems (ABUS) Description and Business Overview
6.14.3 Theraclion Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.14.4 Theraclion Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.14.5 Theraclion Recent Developments/Updates
6.15 Real Imaging
6.15.1 Real Imaging Corporation Information
6.15.2 Real Imaging Automated Breast Ultrasound Systems (ABUS) Description and Business Overview
6.15.3 Real Imaging Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.15.4 Real Imaging Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.15.5 Real Imaging Recent Developments/Updates
6.16 MetriTrack
6.16.1 MetriTrack Corporation Information
6.16.2 MetriTrack Automated Breast Ultrasound Systems (ABUS) Description and Business Overview
6.16.3 MetriTrack Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.16.4 MetriTrack Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.16.5 MetriTrack Recent Developments/Updates
6.17 Toshiba Company
6.17.1 Toshiba Company Corporation Information
6.17.2 Toshiba Company Automated Breast Ultrasound Systems (ABUS) Description and Business Overview
6.17.3 Toshiba Company Automated Breast Ultrasound Systems (ABUS) Sales, Revenue and Gross Margin (2017-2023)
6.17.4 Toshiba Company Automated Breast Ultrasound Systems (ABUS) Product Portfolio
6.17.5 Toshiba Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automated Breast Ultrasound Systems (ABUS) Industry Chain Analysis
7.2 Automated Breast Ultrasound Systems (ABUS) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automated Breast Ultrasound Systems (ABUS) Production Mode & Process
7.4 Automated Breast Ultrasound Systems (ABUS) Sales and Marketing
7.4.1 Automated Breast Ultrasound Systems (ABUS) Sales Channels
7.4.2 Automated Breast Ultrasound Systems (ABUS) Distributors
7.5 Automated Breast Ultrasound Systems (ABUS) Customers
8 Automated Breast Ultrasound Systems (ABUS) Market Dynamics
8.1 Automated Breast Ultrasound Systems (ABUS) Industry Trends
8.2 Automated Breast Ultrasound Systems (ABUS) Market Drivers
8.3 Automated Breast Ultrasound Systems (ABUS) Market Challenges
8.4 Automated Breast Ultrasound Systems (ABUS) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
GE Healthcare
Hitachi
Koninklijke Philips N.V.
Siemens
SonoCine
QView Medical
Seno Medical Instruments
Volpara Solutions
Delphinus Medical Technologies
CapeRay
SuperSonic Imagine
Nova Medical Imaging TechnologyLtd.
Shantou Institute of Ultrasonic Instruments (SIUI)
Theraclion
Real Imaging
MetriTrack
Toshiba Company
Request Sample